Burkholderia cepacia: Management issues and new insights

Clinics in Chest Medicine

Volumn 19, Issue 3, 1998, Pages 473-486

  LiPuma, J J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; LUNG TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TAXONOMY;

EID: 0031660253     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70094-0     Document Type: Article

References (121)

1. D.J. Anderson G. Kuhns M.L. Vessel DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia from a nosocomial outbreak J Clin Microbiol 29 1991 648
2. R.M. Aris P.H. Gilligan I.P. Neuringer The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome Am J Respir Crit Care Med 155 1997 1699
3. S.C. Aronoff F.J. Quinn R.C. Stern Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis Pediatr Pulmonol 11 1991 289
4. P.M. Barker R.E. Wood P.H. Gilligan Lung infection with Burkholderia gladioli in a child with cystic fibrosis: Acute clinical and spirometric deterioration Pediatr Pulmonol 23 1997 123
5. I.A. Baxter P.A. Lambert I.N. Simpson Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli J Antimicrob Chemother 39 1997 169
6. R.L. Berkelman S. Lewin J.R. Allen Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia Ann Intern Med 95 1981 32
7. J. Blessing J. Walker B. Maybury Pseudomonas cepacia and maltophilia in the cystic fibrosis patient [abstract] Am Rev Respir Dis 119 Suppl 1979 262
8. P. Brown S. Butler J. Nelson Pseudomonas cepacia in adult cystic fibrosis: Accelerated decline in lung function and increased mortality Thorax 48 1993 425
9. D.R. Burdge E.M. Nakielna M.A. Noble Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis Infect Control Hosp Epidemiol 14 1993 127
10. D.R. Burdge M.A. Noble M.E. Campbell Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: A diagnostic pitfall with major clinical implications Clin Infect Dis 20 1995 445
11. W.H. Burkholder Sour skin, a bacterial rot of onion bulbs Phytopathology 40 1950 115
12. J.L. Burns Treatment of cepacia : In search of the magic bullet [abstract] Pediatr Pulmonol Suppl 14 1997 90
13. J.L. Burns M. Jonas E.Y. Chi Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia Infect Immun 64 1996 4054
14. J.L. Burns D.M. Lien L.A. Hedin Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia Antimicrob Agent Chemother 33 1989 1247
15. J.L. Burns C.D. Wadsworth J.J. Barry Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance Antimicrob Agent Chemother 40 1996 307
16. S.L. Butler C.J. Doherty J.E. Hughes Burkholderia cepacia and cystic fibrosis: Do natural environments present a potential hazard? J Clin Microbiol 33 1995 1001
17. Butler SL, Nelson JW, Poxton IR, et al: Cell surface characteristics of Pseudomonas cepacia isolates from patients with cystic fibrosis [abstract]. Proceedings of the XIth International Cystic Fibrosis Congress. Dublin, Irish Cystic Fibrosis Foundation, 1992.
18. P.W. Campbell J.A. Phillips G.J. Heidecker Detection of Pseudomonas (Burkholderia) cepacia using PCR Pediatr Pulmonol 20 1995 44
19. L.A. Carson O.C. Tablan L.B. Cusick Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources J Clin Microbiol 26 1988 2096
20. G. Cazzola G. Amalfitano E. Tonolli Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: A genome finger-printing study Acta Paediatr 85 1996 554
21. C. Chaparro D. Chamberlain J. Maurer Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients Chest 110 1996 1150
22. C. Chiesa P.H. Labrozzi S.C. Aranoff Decreased baseline β-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis Pediatr Res 20 1986 1174
23. R.C. Cohn L. Rudzienski Substituted amines synergistic with tobramycin against Burkholderia cepacia in vitro Chemother 43 1997 100
24. J.E. Corkill P.R. Sisson A. Smyth Application of pyrolysis mass spectroscopy and SDS-PAGE in the study of the epidemiology of Pseudomonas cepacia in cystic fibrosis J Med Microbiol 41 1994 106
25. D.E. Craven B. Moody M.G. Connolly Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia N Engl J Med 305 1981 621
26. R.H. Dailey E.J. Benner Necrotizing pneumonitis due to the pseudomonad “eugonic oxidizer-group 1.” N Engl J Med 279 1968 361
27. D.J. Davidson J.R. Dorin McLachlan Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens Nature Genetics 9 1995 351
28. G. Doring S. Jansen H. Noll Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward Pediatr Pulmonol 21 1996 90
29. J.A. Drabick E.J. Gracey G.J. Heidecker Survival of Burkholderia cepacia on environmental surfaces J Hosp Infect 32 1996 267
30. G.M. Ederer J.M. Matsen Colonization and infection with Pseudomonas cepacia J Infect Dis 125 1972 613
31. G. Elborn M. Dodd J. Maddison Clinical and inflammatory responses in CF patients infected with Pseudomonas aeruginosa and Pseudomonas cepacia Pediatr Pulmonol Suppl 10 1994 287
32. E. Ensor H. Humphreys D. Peckham Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? J Hosp Infect 32 1996 9
33. M.C. Fisher J.J. LiPuma S.E. Dasen Source of Pseudomonas cepacia : Ribotyping of isolates from patients and from the environment J Pediatr 123 1993 745
34. A.R. Gessner J.E. Mortensen Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis J Med Microbiol 33 1990 115
35. 2-fixing isolates from rice in Vietnam Int J Syst Bacteriol 45 1995 274
36. D.A. Goldmann J.D. Klinger Pseudomonas cepacia : biology, mechanisms of virulence, epidemiology J Pediatr 108 1986 806
37. R. Goldstein L. Sun R.-Z. Jiang Structurally variant classes of pilus appendage fibers coexpresses from Burkholderia (Pseudomonas) cepacia J Bacteriol 177 1995 1039
38. J.R.W. Govan V. Deretic Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia Microbiol Rev 60 1996 539
39. J.R.W. Govan P.H. Brown J. Maddison Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis Lancet 342 1993 15
40. J.R.W. Govan J.A.M. Fyfe T.R. Jarman Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida , and Pseudomonas mendocina J Gen Microbiol 125 1981 217
41. J.R.W. Govan J.E. Hughes P. Vandamme Burkholderia cepacia : Medical, taxonomic and ecological issues J Med Microbiol 45 1996 395
42. K.A. Hardy K.L. McGowan M.C. Fisher Pseudomonas cepacia in the hospital setting: Lack of transmission between cystic fibrosis patients J Pediatr 109 1986 51
43. J.E. Hearst K.E. Elliott Identifying the killer in cystic fibrosis Nature Med 1 1995 626
44. D.A. Henry M.E. Campbell J.J. LiPuma Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium J Clin Microbiol 35 1997 614
45. J.E. Hughes J. Stewart G.R. Barclay Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia Infect Immun 65 1997 4281
46. H. Humphreys D. Peckham P. Patel Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis Thorax 49 1994 1157
47. G.R. Hutchinson S. Parker J.A. Pryor Home-use nebulizers: A potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis J Clin Microbiol 34 1996 584
48. L. Imundo J. Barasch A. Prince Cystic fibrosis epithelial cella have a receptor for pathogenic bacteria on their apical surface Proc Natl Acad Sci U S A 92 1995 3019
49. A. Isles I. Maclusky M. Corey Pseudomonas cepacia infection in cystic fibrosis: An emerging problem J Pediatr 104 1984 206
50. M. John E. Ecclestone E. Hunter Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis Pediatr Pulmonol 18 1994 108
51. W.M. Johnson S.D. Tyler K.R. Rozee Linkage analysis of geographical and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping J Clin Microbiol 32 1994 924
52. F. Karpati J. Jonasson Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis Molec Cell Probes 10 1996 397
53. D.L. Kiska A. Kerr M.C. Jones Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis J Clin Microbiol 34 1996 886
54. R.M. Kotloff J.B. Zuckerman Lung transplantation for cystic fibrosis: Special considerations Chest 109 1996 787
55. L.R. Laraya-Cuasay M. Lipstein N.N. Huang Pseudomonas cepacia in the respiratory flora of patients with cystic fibrosis [abstract] Pediatr Pulmonol 11 1977 502
56. T.G. Lessie W. Hendrickson B.D. Manning Genomic complexity and plasticity of Burkholderia cepacia FEMS Lett 144 1996 117
57. L.O. Lewin P.J. Byard P.B. Davis Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients J Clin Epidemiol 43 1990 125
58. J.J. LiPuma S.E. Dasen D.W. Nielson Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis Lancet 336 1990 1094
59. J.J. LiPuma M.C. Fisher S.E. Dasen Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia J Infect Dis 164 1991 133
60. J.J. LiPuma G. Heidecker T.L. Stull PCR-based detection and typing of Pseudomonas cepacia [abstract] Pediatr Res 35 1994 394A
61. J.J. LiPuma D. Henry F. Mehar Misidentification of Burkholderia cepacia [abstract] Pediatr Res 41 1997 304A
62. J.J. LiPuma K.A. Marks-Austin D.S. Holsclaw Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis Pediatr Infect Dis J 13 1994 716
63. J.J. LiPuma J.E. Mortensen S.E. Dasen Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers J Pediatr 113 1988 859
64. E. Mahenthiralingam M.E. Campbell D.A. Henry Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis J Clin Microbiol 35 1997 2914
65. E. Mahenthiralingam D.A. Henry P. Vandamme Biochemical and genetic characteristics of epidemic strains of Burkholderia cepacia recovered from patients with cystic fibrosis [abstract] Pediatr Pulmonol Suppl 14 1997 290
66. B.R. McKay D.P. Speert A Burkholderia cepacia mutant with altered membrane permeability causing increased susceptibility to cationic peptides [abstract] Pediatr Pulmonol Suppl 14 1997 323
67. L. Millar-Jones A. Paull Z. Saunders Transmission of Pseudomonas cepacia among cystic fibrosis patients Lancet 340 1992 491
68. J.E. Mortensen M.C. Fisher J.J. LiPuma Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment Infect Control Hosp Epidemiol 16 1995 30
69. K. Muhdi F.P. Edenborough L. Gummery Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic Thorax 51 1996 374
70. G.M. Mukwaya D.F. Welch Subgrouping of Pseudomonas cepacia by cellular fatty acid composition J Clin Microbiol 27 1989 2640
71. J.W. Nelson C.J. Doherty P.H. Brown Pseudomonas cepacia in inpatients with cystic fibrosis Lancet 338 1991 1525
72. J.W. Nelson S.L. Butler P.H. Brown Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis J Med Microbiol 39 1993 39
73. J.W. Nelson S.L. Butler D. Krieg Virulence factors of Burkholderia cepacia FEMS Immunol Med Microbiol 8 1994 89
74. G. Nolan P. McIvor H. Levison Antibiotic prophylaxis in cystic fibrosis: Inhaled cephaloridine as an adjunct to oral cloxacillin J Pediatr 101 1982 626
75. B.E. Noyes M.G. Michaels G. Kurland Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis Chest 105 1994 1888
76. E.M. O'Callaghan M.S. Tanner G.J. Boulnois Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia J Clin Pathol 47 1994 222
77. R.W. Palfreyman M.L. Watson C. Eden Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products Infect Immun 65 1997 617
78. N.J. Palleroni R. Kunisawa R. Contopoulou Nucleid acid homologies in the genus Pseudomonas Int J Syst Bacteriol 23 1973 333
79. C.F. Pegues D.A. Pegues D.S. Ford Burkholderia cepacia respiratory tract acquisition: Epidemiology and molecular characterization of a large nosocomial outbreak Epidemiol Infect 116 1996 309
80. D.A. Pegues L.A. Carson O.C. Tablan Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group J Pediatr 124 1994 694
81. D.A. Pegues D.V. Schidlow O.C. Tablan Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis Arch Pediatr Adolesc Med 148 1994 805
82. I. Phillips S. Eykyn M.A. Curtis Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit Lancet 1 1971 375
83. G.B. Pier M. Grout T.S. Zaidi Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infection Science 271 1996 64
84. K.C. Pitchford M. Corey A.K. Highsmith Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment J Pediatr 111 1987 212
85. T.L. Pitt M.E. Kaufmann P.S. Patel Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland J Med Microbiol 44 1996 203
86. R.H. Poe H.R. Marcus G.L. Emerson Lung abscess due to Pseudomonas cepacia Am Rev Respir Dis 115 1977 861
87. H. Revets P. Vandamme A. Van Zeebroeck Burkholderia (Pseudomonas) cepacia and cystic fibrosis: The epidemiology in Belgium Acta Clin Belg 51 1996 222
88. B.J. Rosenstein D.E. Hall Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis Johns Hopkins Med J 147 1980 188
89. H.C. Ryley L. Millar-Jones A. Paull Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping J Med Microbiol 43 1995 436
90. H.C. Ryley B. Objemiyi N. Hoiby Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients Eur J Clin Microbiol Infect Dis 15 1996 755
91. U.S. Sajjan J.F. Forstner Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis Infect Immun 60 1992 1434
92. U.S. Sajjan M. Corey M.A. Karmali Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis J Clin Invest 89 1992 648
93. U.S. Sajjan L. Sun R. Goldstein Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia : Nucleotide sequence of cblA major subunit pilin gene and novel morphology of the assembled appendage fibers J Bacteriol 177 1995 1030
94. D. Shaw I.R. Poxton J.R.W. Govan Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide FEMS Immunol Med Microbiol 11 1995 99
95. M.R. Shreve S.J. Johnson C.E. Milla PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection Am J Respir Crit Care Med 155 1997 984
96. E.J. Simmonds S.P. Conway A.T.M. Ghoneim Pseudomonas cepacia : A new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom Arch Dis Child 65 1990 874
97. I.N. Simpson J. Finlay D.J. Winstanley Multi-resistant isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis J Antimicrob Chemother 34 1994 353
98. D.L. Smith L.B. Gumery E.G. Smith Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: Evidence of person-to-person transmission J Clin Microbiol 31 1993 3017
99. J.J. Smith S.M. Travis E.P. Greenberg Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229
100. G.I. Snell A. de Hoyos M. Krajden Pseudomonas cepacia in lung transplant recipients with cystic fibrosis Chest 103 1993 466
101. J.D. Sobel N. Hashman G. Reinherz Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination Am J Med 73 1982 183
102. P.A. Sokol Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia J Clin Microbiol 23 1986 560
103. P.A. Sokol C.J. Lewis J.J. Dennis Isolation of a novel siderophore from Pseudomonas cepacia J Med Microbiol 36 1992 184
104. D.P. Speert M. Bond R.C. Woodman Infection with Pseudomonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophils in host defense J Infect Dis 170 1994 1524
105. A.C. Steere J.H. Tenney D.C. Mackel Pseudomonas species bacteremia caused by contaminated human serum albumin J Infect Dis 135 1977 729
106. S. Steinbach L. Sun R. Jiang Transmissibility of Pseudomonas cepacia infection in clinic patients and lung transplant recipients with cystic fibrosis N Engl J Med 331 1994 981
107. L. Sun R.-Z. Jiang S. Steinbach The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain Nature Med 1 1995 661
108. O.C. Tablan L.A. Carson L.B. Cusick Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis J Clin Microbiol 25 1987 485
109. O.C. Tablan T.L. Chorba D.V. Schidlow Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcome J Pediatr 107 1985 382
110. O.C. Tablan W.J. Martone C.F. Doershuk Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes Chest 91 1987 527
111. C.J. Taylor J.R. Hoeden T. Smith Pseudomonas cepacia Arch Dis Child 70 1994 358
112. R.F. Taylor H. Gaya M.E. Hodson Pseudomonas cepacia : Pulmonary infection in patients with cystic fibrosis Resp Med 87 1993 187
113. M.J. Thomassen C.A. Demko C.F. Doershuk Pseudomonas cepacia : Decrease in colonization in patients with cystic fibrosis Am Rev Respir Dis 134 1986 669
114. M.J. Thomassen C.A. Demko J.D. Klinger Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist Am Rev Respir Dis 131 1985 791
115. H. Vu-Thien D. Moissenet M. Valcin Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia , and Alcaligenes xylosoxidans in a cystic fibrosis center Eur J Clin Microbiol Infect Dis 15 1996 876
116. Whitby PW, Dick HLN, Campbell PW, et al: Comparison of culture and PCR detection of Burkholderia cepacia in sputum of patients with cystic fibrosis. J Clin Microbiol, in press
117. M.L. Whiteford J.D. Wilkinson McColl Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak Thorax 50 1995 1194
118. M.L. Wilsher J. Kolbe A.J. Morris Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis Am J Respir Crit Care Med 155 1997 1436
119. E. Yabuuchi Y. Kosako H. Oyaizu Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov Microbiol Immunol 36 1992 1251
120. E. Yabuuchi Y. Kosako I. Yano Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: Proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff 1973) comb. nov., Ralstonia solanacearum (Smith 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov Microbiol Immunol 39 1995 897
121. P. Vandamme B. Holmes M. Vancanneyt Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients: Proposal of Burkholderia multivorans sp. nov Int J Syst Bacteriol 47 1997 1188